Literature DB >> 10990197

The effect of two azones on the lateral lipid organization of human stratum corneum and its permeability.

G S Pilgram1, A M Engelsma-van Pelt, H K Koerten, J A Bouwstra.   

Abstract

PURPOSE: Investigation of the relationship between changes in human SC lipid organization induced by N-alkyl-azocycloheptane-2-one and SC permeability to the model compound HgCl2.
METHODS: Human dermatomed skin was treated with propylene glycol (PG), oleyl-Azone (OAz) or dodecyl-Azone (DAz) in 0.15 M PG. Untreated skin served as control. The lateral lipid organization was studied by electron diffraction. Hg was measured on tape-strips by X-ray microanalysis and in the acceptor phase by atom absorption spectrometry.
RESULTS: In control and PG treated samples, the lipid packing was mainly orthorhombic, while a small fraction was hexagonal. In OAz and DAz treated samples, the orthorhombic lipid organization remained, however, the hexagonal packing was recorded less frequently. The amount of Hg decreased as a function of depth in all SC samples, however, the penetration profile increased significantly upon OAz treatment. The cumulative amount of Hg in the acceptor phase of OAz treated samples also increased significantly compared to control and PG treated samples.
CONCLUSIONS: The increased penetration of Hg into OAz treated skin could not be related to an orthorhombic-hexagonal phase transition. Alternatively, phase separation of OAz and/or formation of grain boundaries might affect SC permeability, hereby increasing Hg penetration. A similar mechanism is proposed for DAz.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10990197     DOI: 10.1023/a:1007547906856

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  14 in total

1.  Phase transitions of rat stratum corneum lipids by an electron paramagnetic resonance study and relationship of phase states to drug penetration.

Authors:  T Ogiso; H Ogiso; T Paku; M Iwaki
Journal:  Biochim Biophys Acta       Date:  1996-05-31

2.  Study on the lipid organization of stratum corneum lipid models by (cryo-) electron diffraction.

Authors:  G S Pilgram; A M Engelsma-van Pelt; G T Oostergetel; H K Koerten; J A Bouwstra
Journal:  J Lipid Res       Date:  1998-08       Impact factor: 5.922

3.  Permeability of acetic acid across gel and liquid-crystalline lipid bilayers conforms to free-surface-area theory.

Authors:  T X Xiang; B D Anderson
Journal:  Biophys J       Date:  1997-01       Impact factor: 4.033

4.  Evidence that oleic acid exists in a separate phase within stratum corneum lipids.

Authors:  B Ongpipattanakul; R R Burnette; R O Potts; M L Francoeur
Journal:  Pharm Res       Date:  1991-03       Impact factor: 4.200

Review 5.  Controlled topical delivery of drugs for systemic action.

Authors:  J E Shaw; S K Chandrasekaran
Journal:  Drug Metab Rev       Date:  1978       Impact factor: 4.518

6.  The influence of an electric field on ion and water accessibility to stratum corneum lipid lamellae.

Authors:  L A Pechtold; W Abraham; R O Potts
Journal:  Pharm Res       Date:  1996-08       Impact factor: 4.200

7.  Cryo-electron diffraction as a tool to study local variations in the lipid organization of human stratum corneum.

Authors:  G S Pilgram; A M Van Pelt; F Spies; J A Bouwstra; H K Koerten
Journal:  J Microsc       Date:  1998-01       Impact factor: 1.758

8.  Intracellular or intercellular localization of the polar pathway of penetration across stratum corneum.

Authors:  M Sznitowska; S Janicki; A C Williams
Journal:  J Pharm Sci       Date:  1998-09       Impact factor: 3.534

9.  Dithionite penetration through phospholipid bilayers as a measure of defects in lipid molecular packing.

Authors:  M Langner; S W Hui
Journal:  Chem Phys Lipids       Date:  1993-04       Impact factor: 3.329

10.  Phase coexistence in cholesterol-fatty acid mixtures and the effect of the penetration enhancer Azone.

Authors:  J Engblom; S Engström; B Jönsson
Journal:  J Control Release       Date:  1998-03-31       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.